ORLANDO, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) today released Part 3 of its Investor Education Series, outlining the Company’s capital allocation framework and how SDL’s public platform accelerates acquisitions and integration. With Regulation A qualification expanding access to growth capital, SDL intends to pair cash with equity consideration and disciplined earn-outs to compete for quality labs while preserving flexibility for post-close integration.

Part 3 details acquisition criteria, deal structures, capital priorities, and SDL’s path to broader market visibility as it scales.

“Capital is the catalyst that turns our roll-up flywheel,” said James Brooks, CEO of Standard Dental Labs. “Our job is to deploy it with discipline—buy well, integrate fast, and compound margins—so every acquisition makes the whole stronger.”

Acquisition Criteria

• Established independent labs with durable clinic relationships and positive cash flow.
• Cultural fit and owner alignment (succession/retention plans for key technicians).
• Operational readiness for SOP adoption and digital tooling.
• Attractive unit economics and proximity to target hubs/metros.

Deal Structures & Discipline

• Balanced consideration: mix of cash, stock, and performance-based earn‑outs to align incentives and protect downside.
• Valuation guardrails: focus on accretive multiples and clear synergy roadmaps pre‑signing.
• Integration budget: earmark post‑close investments (tooling, training, systems) to accelerate margin capture.
  

Capital Allocation Priorities

• 1) Accretive acquisitions; 2) Integration/hub buildouts; 3) Technology and training; 4) Working capital and prudent reserves.
  

Balance Sheet & Uplisting Path

• Leverage the transparency of the OTCQB listing while preparing financial scale and governance for a potential senior exchange uplist.
• Expand investor base via consistent updates on closings, run‑rate, and margin trajectory.

Shareholder Scorecard (Capital Edition)

• Deal pace (LOIs → definitive agreements → closings) and average consideration mix.
• Post‑close margin uplift versus underwriting model.
• Cash conversion cycle and liquidity runway.
• Dilution management and return on invested capital (ROIC).

Series Navigation

Previously in this series → Part 1 and Part 2. All parts and future updates: https://sdl.care/investors.

About Standard Dental Labs Inc.

Standard Dental Labs Inc. (OTCQB: TUTH) is a Florida-based dental laboratory consolidator dedicated to acquiring, integrating, and scaling high-performing labs through shared systems, digital infrastructure, and operational excellence. SDL’s mission is to unify independent laboratories under one standard of quality, service, and efficiency.
Learn more at https://sdl.care or contact info@sdl.care.

Forward-Looking Statements

This press release may contain forward-looking statements, including statements regarding the Company’s plans, expectations, and timing relating to the proposed acquisitions; the anticipated benefits of the transaction; ongoing acquisition negotiations with other labs; and future performance.

Forward-looking statements are based on current expectations and involve inherent risks and uncertainties that could cause actual results to differ materially.

Specific to this announcement, there can be no assurance that any acquisition will be completed as contemplated, or at all. The transaction remains subject to the completion and satisfactory results of the Company’s due diligence review, as well as customary closing conditions. Findings during the due diligence process could alter, delay, or prevent closing of the transaction, or result in modifications to the agreed terms. Similarly, there can be no assurance that negotiations with other laboratories will result in definitive agreements or completed transactions. Additionally, even if one or more of these transactions close, the integration of acquired labs may not achieve the expected operational efficiencies, synergies, or financial performance.

More generally, these risks include, but are not limited to: the outcomes of due diligence; the ability to negotiate and execute definitive agreements on favorable terms, or at all; the availability of financing for acquisitions; the ability to successfully integrate acquired businesses and realize anticipated synergies; market competition; and other risks and uncertainties detailed in the Company’s filings, including its Form 1-A/A filed with the U.S. Securities and Exchange Commission on July 25, 2025, and disclosures furnished to OTC Markets.

Standard Dental Labs Inc. undertakes no obligation to update or revise any forward-looking statements, except as required by law.

Investor & Media Contact

Standard Dental Labs Inc.
424 E Central Blvd, Suite 308, Orlando, FL 32801
Phone: (407) 789-1923 • Email: info@sdl.care • Investors: https://sdl.care/investors

SOURCE: Standard Dental Labs Inc.